140 related articles for article (PubMed ID: 37697676)
1. Reduced expression of transmembrane protein 43 during cardiac hypertrophy leads to worsening heart failure in mice.
Gu Y; Yao YR; Ding Y; Zhang XW
Exp Biol Med (Maywood); 2023 Sep; 248(17):1437-1445. PubMed ID: 37697676
[TBL] [Abstract][Full Text] [Related]
2. Leukocyte immunoglobulin-like receptor B4 protects against cardiac hypertrophy via SHP-2-dependent inhibition of the NF-κB pathway.
Zhou H; Li N; Yuan Y; Jin YG; Wu Q; Yan L; Bian ZY; Deng W; Shen DF; Li H; Tang QZ
J Mol Med (Berl); 2020 May; 98(5):691-705. PubMed ID: 32280997
[TBL] [Abstract][Full Text] [Related]
3. Tumor Necrosis Factor-
Yao R; Kong L; Yang C; Du J; Zhao G; Li Y
Oxid Med Cell Longev; 2022; 2022():9469143. PubMed ID: 35528518
[TBL] [Abstract][Full Text] [Related]
4. The nuclear receptor RORα protects against angiotensin II-induced cardiac hypertrophy and heart failure.
Beak JY; Kang HS; Huang W; Myers PH; Bowles DE; Jetten AM; Jensen BC
Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H186-H200. PubMed ID: 30387679
[TBL] [Abstract][Full Text] [Related]
5. Tax1 banding protein 1 exacerbates heart failure in mice by activating ITCH-P73-BNIP3-mediated cardiomyocyte apoptosis.
Wu QQ; Yao Q; Hu TT; Wan Y; Xie QW; Zhao JH; Yuan Y; Tang QZ
Acta Pharmacol Sin; 2022 Oct; 43(10):2562-2572. PubMed ID: 35948751
[TBL] [Abstract][Full Text] [Related]
6. NF-kappaB activation is required for adaptive cardiac hypertrophy.
Zelarayan L; Renger A; Noack C; Zafiriou MP; Gehrke C; van der Nagel R; Dietz R; de Windt L; Bergmann MW
Cardiovasc Res; 2009 Dec; 84(3):416-24. PubMed ID: 19620128
[TBL] [Abstract][Full Text] [Related]
7. Loss of LRRC25 accelerates pathological cardiac hypertrophy through promoting fibrosis and inflammation regulated by TGF-β1.
Zhang X; Zhang MC; Wang CT
Biochem Biophys Res Commun; 2018 Nov; 506(1):137-144. PubMed ID: 30340835
[TBL] [Abstract][Full Text] [Related]
8. Tripartite motif 32 prevents pathological cardiac hypertrophy.
Chen L; Huang J; Ji Y; Zhang X; Wang P; Deng K; Jiang X; Ma G; Li H
Clin Sci (Lond); 2016 May; 130(10):813-28. PubMed ID: 26884348
[TBL] [Abstract][Full Text] [Related]
9. TMEM43 Protects against Sepsis-Induced Cardiac Injury via Inhibiting Ferroptosis in Mice.
Chen Z; Cao Z; Gui F; Zhang M; Wu X; Peng H; Yu B; Li W; Ai F; Zhang J
Cells; 2022 Sep; 11(19):. PubMed ID: 36230956
[TBL] [Abstract][Full Text] [Related]
10. MG53, A Novel Regulator of KChIP2 and I
Liu W; Wang G; Zhang C; Ding W; Cheng W; Luo Y; Wei C; Liu J
Circulation; 2019 Apr; 139(18):2142-2156. PubMed ID: 30760025
[TBL] [Abstract][Full Text] [Related]
11. Caspase recruitment domain 6 protects against cardiac hypertrophy in response to pressure overload.
Li L; Chen W; Zhu Y; Wang X; Jiang DS; Huang F; Wang L; Xiang F; Qin W; Wang Q; Zhang R; Zhu X; Li H; Chen X
Hypertension; 2014 Jul; 64(1):94-102. PubMed ID: 24777975
[TBL] [Abstract][Full Text] [Related]
12. Bakuchiol protects against pathological cardiac hypertrophy by blocking NF-κB signaling pathway.
Wang Z; Gao L; Xiao L; Kong L; Shi H; Tian X; Zhao L
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30242058
[TBL] [Abstract][Full Text] [Related]
13. JMJD6 protects against isoproterenol-induced cardiac hypertrophy via inhibition of NF-κB activation by demethylating R149 of the p65 subunit.
Guo Z; Hu YH; Feng GS; Valenzuela Ripoll C; Li ZZ; Cai SD; Wang QQ; Luo WW; Li Q; Liang LY; Wu ZK; Zhang JG; Javaheri A; Wang L; Lu J; Liu PQ
Acta Pharmacol Sin; 2023 Sep; 44(9):1777-1789. PubMed ID: 37186122
[TBL] [Abstract][Full Text] [Related]
14. TRIM-containing 44 aggravates cardiac hypertrophy via TLR4/NOX4-induced ferroptosis.
Wu L; Jia M; Xiao L; Wang Z; Yao R; Zhang Y; Gao L
J Mol Med (Berl); 2023 Jun; 101(6):685-697. PubMed ID: 37119283
[TBL] [Abstract][Full Text] [Related]
15. Smad Nuclear Interacting Protein 1 Acts as a Protective Regulator of Pressure Overload-Induced Pathological Cardiac Hypertrophy.
Lu YY; Xu DC; Zhao YF; Zhu GF; Zhu MY; Liu WJ; Yu XJ; Chen W; Liu Z; Xu YW
J Am Heart Assoc; 2016 Oct; 5(11):. PubMed ID: 27912208
[TBL] [Abstract][Full Text] [Related]
16. Severe Cardiac Dysfunction and Death Caused by Arrhythmogenic Right Ventricular Cardiomyopathy Type 5 Are Improved by Inhibition of Glycogen Synthase Kinase-3β.
Padrón-Barthe L; Villalba-Orero M; Gómez-Salinero JM; Domínguez F; Román M; Larrasa-Alonso J; Ortiz-Sánchez P; Martínez F; López-Olañeta M; Bonzón-Kulichenko E; Vázquez J; Martí-Gómez C; Santiago DJ; Prados B; Giovinazzo G; Gómez-Gaviro MV; Priori S; Garcia-Pavia P; Lara-Pezzi E
Circulation; 2019 Oct; 140(14):1188-1204. PubMed ID: 31567019
[TBL] [Abstract][Full Text] [Related]
17. JIP3 deficiency attenuates cardiac hypertrophy by suppression of JNK pathway.
Ma Q; Liu Y; Chen L
Biochem Biophys Res Commun; 2018 Sep; 503(1):1-7. PubMed ID: 29604277
[TBL] [Abstract][Full Text] [Related]
18. Integrin beta-like 1 mediates fibroblast-cardiomyocyte crosstalk to promote cardiac fibrosis and hypertrophy.
Chen X; Li X; Wu X; Ding Y; Li Y; Zhou G; Wei Y; Chen S; Lu X; Xu J; Liu S; Li J; Cai L
Cardiovasc Res; 2023 Aug; 119(10):1928-1941. PubMed ID: 37395147
[TBL] [Abstract][Full Text] [Related]
19. Nuclear Localization Leucine-Rich-Repeat Protein 1 Deficiency Protects Against Cardiac Hypertrophy by Pressure Overload.
Zong J; Li FF; Liang K; Dai R; Zhang H; Yan L; Liu JL; Xu LH; Qian WH
Cell Physiol Biochem; 2018; 48(1):75-86. PubMed ID: 30001530
[TBL] [Abstract][Full Text] [Related]
20. Toll-interacting protein (Tollip) negatively regulates pressure overload-induced ventricular hypertrophy in mice.
Liu Y; Jiang XL; Liu Y; Jiang DS; Zhang Y; Zhang R; Chen Y; Yang Q; Zhang XD; Fan GC; Li H
Cardiovasc Res; 2014 Jan; 101(1):87-96. PubMed ID: 24285748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
